BIO-key International Inc. (NASDAQ:BKYI – Get Free Report) was the target of a significant increase in short interest in the month of July. As of July 31st, there was short interest totaling 63,876 shares, an increase of 4,465.8% from the July 15th total of 1,399 shares. Approximately 6.1% of the shares of the stock are sold short. Based on an average trading volume of 231,601 shares, the days-to-cover ratio is currently 0.3 days.
Institutional Trading of BIO-key International
A hedge fund recently raised its position in BIO-key International stock. Geode Capital Management LLC lifted its holdings in BIO-key International Inc. (NASDAQ:BKYI – Free Report) by 49.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 48,892 shares of the technology company’s stock after acquiring an additional 16,271 shares during the period. Geode Capital Management LLC owned 0.45% of BIO-key International worth $26,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 26.51% of the company’s stock.
Analysts Set New Price Targets
A number of research firms have recently weighed in on BKYI. Zacks Research raised BIO-key International to a “hold” rating in a research note on Thursday, August 6th. Weiss Ratings reissued a “sell (e+)” rating on shares of BIO-key International in a research note on Friday, July 17th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Reduce”.
BIO-key International Price Performance
Shares of BKYI opened at $3.90 on Wednesday. The stock has a market capitalization of $4.25 million, a price-to-earnings ratio of -0.70 and a beta of 0.44. BIO-key International has a 1 year low of $3.10 and a 1 year high of $19.70. The business’s 50 day simple moving average is $4.38 and its 200-day simple moving average is $5.28.
BIO-key International Company Profile
BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.
In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.
Recommended Stories
- Five stocks we like better than BIO-key International
- Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
- AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be
- NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
- Apple’s Next iPhone Could Test How Much Pricing Power Is Left
Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.
